Literature DB >> 15338397

Cardiac arrhythmias due to severe hypokalemia in a patient with classic Bartter disease.

Cristina Malafronte1, Nicolò Borsa, Silvana Tedeschi, Marie-Louise Syrèn, Sara Stucchi, Mario Giovanni Bianchetti, Felice Achilli, Alberto Bettinelli.   

Abstract

We report a young girl with classic Bartter disease (type III) with severe hypokalemia (< or = 2.0 mmol/l) who developed a prolonged heart rate-corrected QT interval of 510 ms (upper reference 430 ms) and ST segment depression in all leads. Holter electrocardiography was performed (with a plasma potassium level of 2.0 mmol/l) and it disclosed a stable sinus rhythm, a prolonged correct QT interval, more-evident ST segment depression during an increase in heart rate, a few single premature ventricular complexes, and nocturnal conduction abnormalities such as second-degree atrioventricular block 2:1. In the light of these results, the treatment was modified by increasing indomethacin from 1.5 to 3 mg/kg per day and adding spironolactone at a dose of 5 mg/kg per day. After 10 days, plasma potassium levels increased to 2.7 mmol/l and electrocardiographic abnormalities regressed. No other cardiac abnormalities were noted when the serum potassium was maintained > 2.5 mmol/l. In conclusion, this case report supports the link between arrhythmic events and chronic renal hypokalemic alkalosis in renal tubular disorders. We highlight the importance of standardizing the use of rest electrocardiography and 24-h Holter monitoring to diagnose arrhythmic events in children with severe hypokalemic renal disorders, especially in those with a plasma potassium < 2.5 mmol/l. The importance of beginning early medical treatment, to improve plasma potassium levels and reverse cardiac abnormalities, is emphasized.

Entities:  

Mesh:

Year:  2004        PMID: 15338397     DOI: 10.1007/s00467-004-1611-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib.

Authors:  Nikolaus A Haas; Robert Nossal; Christoph H Schneider; Martin A G Lewin; Volker Ocker; Martin Holder; Frank Uhlemann
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

Review 2.  Sudden death in young athletes.

Authors:  Barry J Maron
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

3.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome.

Authors:  C Blomström-Lundqvist; K Caidahl; S B Olsson; A Rudin
Journal:  Br Heart J       Date:  1989-03

5.  Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.

Authors:  Martin Konrad; Martin Vollmer; Henny H Lemmink; Lambertus P W J VAN DEN Heuvel; Nikola Jeck; Rosa Vargas-Poussou; Alicia Lakings; Rainer Ruf; Georges Deschênes; Corinne Antignac; Lisa Guay-Woodford; Nine V A M Knoers; Hannsjörg W Seyberth; Delphine Feldmann; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

6.  Electrocardiographic QT prolongation and sudden death in renal hypokalemic alkalosis.

Authors:  Maura Zanolari Calderari; Rodo O Vigier; Alberto Bettinelli; Mario G Bianchetti
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

7.  Cardiomyopathy in an adult with Bartter's syndrome and hypokalemia. Hemodynamic, angiographic and metabolic studies.

Authors:  J L Potts; T G Dalakos; D H Streeten; D Jones
Journal:  Am J Cardiol       Date:  1977-12       Impact factor: 2.778

8.  Electrocardiogram with prolonged QT interval in Gitelman disease.

Authors:  Alberto Bettinelli; Camillo Tosetto; Giacomo Colussi; Ginaluca Tommasini; Alberto Edefonti; Mario G Bianchetti
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

Review 9.  Prevention of cardiac arrhythmias in pediatric patients with normotensive-hypokalemic tubulopathy. Current attitude among European pediatricians.

Authors:  Cinzia Cortesi; Pietro E G Foglia; Alberto Bettinelli; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2003-08       Impact factor: 3.714

Review 10.  QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.

Authors:  Luigi X Cubeddu
Journal:  Am J Ther       Date:  2003 Nov-Dec       Impact factor: 2.688

View more
  8 in total

Review 1.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

2.  Bartter's Syndrome Masquerading as a Neurometabolic Disorder.

Authors:  H R Ramamurthy; M Kanitkar; U Raju
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Cardiac arrhythmias and rhabdomyolysis in Bartter-Gitelman patients.

Authors:  Cinzia Cortesi; Sebastiano A G Lava; Alberto Bettinelli; Fabiana Tammaro; Olivier Giannini; Maria Caiata-Zufferey; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2010-06-13       Impact factor: 3.714

Review 4.  Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalities.

Authors:  T D Filippatos; C V Rizos; E Tzavella; M S Elisaf
Journal:  Int Urol Nephrol       Date:  2017-07-25       Impact factor: 2.370

5.  Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.

Authors:  Anne Blanchard; Rosa Vargas-Poussou; Marion Vallet; Aurore Caumont-Prim; Julien Allard; Estelle Desport; Laurence Dubourg; Matthieu Monge; Damien Bergerot; Stéphanie Baron; Marie Essig; Frank Bridoux; Ivan Tack; Michel Azizi
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

6.  QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study.

Authors:  Duygu Ovunc Hacihamdioglu; Kursat Fidanci; Ayhan Kilic; Faysal Gok; Rezan Topaloglu
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

Review 7.  Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.

Authors:  Hannsjörg W Seyberth; Karl P Schlingmann
Journal:  Pediatr Nephrol       Date:  2011-04-19       Impact factor: 3.714

Review 8.  Genetic causes of hypomagnesemia, a clinical overview.

Authors:  Daan H H M Viering; Jeroen H F de Baaij; Stephen B Walsh; Robert Kleta; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2016-05-27       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.